v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2024   226,604,138      
Beginning balance at Dec. 31, 2024 $ 29,492 $ 23 $ 1,296,848 $ (1,268,568) $ 1,189
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   112,617      
Exercise of stock options 132   132    
Stock-based compensation 2,405   2,405    
Issuance of common stock pursuant to Employee Stock Purchase Plan (in shares)   504,507      
Issuance of common stock pursuant to Employee Stock Purchase Plan 372   372    
Net loss (36,638)     (36,638)  
Other comprehensive income (loss) (2,013)       (2,013)
Ending balance (in shares) at Mar. 31, 2025   227,221,262      
Ending balance at Mar. 31, 2025 (6,250) $ 23 1,299,757 (1,305,206) (824)
Beginning balance (in shares) at Dec. 31, 2024   226,604,138      
Beginning balance at Dec. 31, 2024 29,492 $ 23 1,296,848 (1,268,568) 1,189
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (74,911)        
Other comprehensive income (loss) (6,277)        
Ending balance (in shares) at Jun. 30, 2025   227,322,528      
Ending balance at Jun. 30, 2025 (46,107) $ 23 1,302,437 (1,343,479) (5,088)
Beginning balance (in shares) at Mar. 31, 2025   227,221,262      
Beginning balance at Mar. 31, 2025 (6,250) $ 23 1,299,757 (1,305,206) (824)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted stock (in shares)   0      
Exercise of stock options (in shares)   101,266      
Exercise of stock options 94   94    
Stock-based compensation 2,586   2,586    
Net loss (38,273)     (38,273)  
Other comprehensive income (loss) (4,264)       (4,264)
Ending balance (in shares) at Jun. 30, 2025   227,322,528      
Ending balance at Jun. 30, 2025 $ (46,107) $ 23 1,302,437 (1,343,479) (5,088)
Beginning balance (in shares) at Dec. 31, 2025 233,677,057 233,677,057      
Beginning balance at Dec. 31, 2025 $ (122,760) $ 24 1,321,303 (1,438,938) (5,149)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   211,460      
Exercise of stock options 220   220    
Stock-based compensation 6,304   6,304    
Issuance of common stock pursuant to Employee Stock Purchase Plan (in shares)   807,765      
Issuance of common stock pursuant to Employee Stock Purchase Plan 292   292    
Net loss (46,664)     (46,664)  
Other comprehensive income (loss) 1,125       1,125
Ending balance (in shares) at Mar. 31, 2026   234,696,282      
Ending balance at Mar. 31, 2026 $ (161,483) $ 24 1,328,119 (1,485,602) (4,024)
Beginning balance (in shares) at Dec. 31, 2025 233,677,057 233,677,057      
Beginning balance at Dec. 31, 2025 $ (122,760) $ 24 1,321,303 (1,438,938) (5,149)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares) 211,460        
Net loss $ (29,764)        
Other comprehensive income (loss) $ 1,415        
Ending balance (in shares) at Jun. 30, 2026 488,846,723 488,846,723      
Ending balance at Jun. 30, 2026 $ (94,029) $ 50 1,378,357 (1,468,702) (3,734)
Beginning balance (in shares) at Mar. 31, 2026   234,696,282      
Beginning balance at Mar. 31, 2026 (161,483) $ 24 1,328,119 (1,485,602) (4,024)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation $ 2,463   2,463    
Issuance of common stock and warrants in connection with the exchange of the 2027 Notes, net of issuance costs (in shares) 254,150,441        
Issuance of common stock and warrants in connection with the exchange of the 2027 Notes, net of issuance costs $ 47,801 $ 26 47,775    
Net loss 16,900     16,900  
Other comprehensive income (loss) $ 290       290
Ending balance (in shares) at Jun. 30, 2026 488,846,723 488,846,723      
Ending balance at Jun. 30, 2026 $ (94,029) $ 50 $ 1,378,357 $ (1,468,702) $ (3,734)